Johnson & Johnson Reports 2016 First-Quarter Results:
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Piper Jaffray Raises Price Target on Johnson & Johnson (JNJ) Following 1Q Report
April 20, 2016 7:42 AM EDTPiper Jaffray reiterated a Neutral rating on Johnson & Johnson (NYSE: JNJ), and raised the price target to $106.00 (from $105.00), following the company's 1Q earnings report. In Pharma, total sales of $8.2B and key drug sales were slightly better than estimates. The Medical Device segment generated revenue of $6.11B,... More
